A biotech breakthrough with a strong Australian link will be giving about 25,000 people Down Under a little more hope....
Read moreDetailsA gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...
Read moreDetailsApproval of the first therapy for geographic atrophy (GA), Syfovre (pegcetacoplan), is being hailed a “landmark moment” for the the...
Read moreDetailsEyewear maker EssilorLuxottica plans to produce 10 million units by the end of next year as it looks to boost production...
Read moreDetailsOphthalmic device distributor BOC Instruments has received TGA registration for its new RetiCam 3100 Plus wide-field fundus camera. In a...
Read moreDetailsGlaukos has received Therapeutic Goods Administration (TGA) approval in Australia for its iStent infinite Trabecular Micro-Bypass System, offering an improved...
Read moreDetailsThe Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...
Read moreDetailsBayer’s high dose aflibercept 8 mg – now approved in the European Union and US – has been labelled...
Read moreDetailsBayer’s higher dose aflibercept 8 mg with extended treatment intervals is set for approval in the European Union (EU) for...
Read moreDetailsThe US Food and Drug Administration (FDA) has issued product warnings for an additional 27 over-the-counter eyedrop products due to...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited